Overcoming Intrinsic Multidrug Resistance in Melanoma by Blocking the Mitochondrial Respiratory Chain of Slow-Cycling JARID1Bhigh Cells
Alexander Roesch(Essen University Hospital), Meenhard Herlyn(The Wistar Institute), Phyllis A. Gimotty(University of Pennsylvania), Matthias W. Laschke(Institut für Sozialforschung und Sozialwirtschaft), Sylvie Pätzold(Goethe University Frankfurt), Clemens Krepler(Merck & Co., Inc., Rahway, NJ, USA (United States)), David W. Speicher(The Wistar Institute), Markus Hoth(Saarland University), Elmar Krause(Saarland University), Boris C. Bastian(University of California, San Francisco), Stephan Philipp(Saarland University), Thomas Vogt(University Dermatology), Katharina Zimmermann(Friedrich-Alexander-Universität Erlangen-Nürnberg), Christina Körbel(Saarland University), Jessie Villanueva(The Wistar Institute), Adina Vultur(The Wistar Institute), Mizuho Fukunaga‐Kalabis(Merck & Co., Inc., Rahway, NJ, USA (United States)), Huan Wang(Peking University), Ivan Bogeski(Nanoscale Microscopy and Molecular Physiology of the Brain Cluster of Excellence 171 — DFG Research Center 103)
Cited by 680
Related Papers
Evaluating the public health impact of health promotion interventions: the RE-AIM framework.
|American Journal of Public Health|1999|7.2k
Final Version of 2009 AJCC Melanoma Staging and Classification
|Journal of Clinical Oncology|2009|4.6k
Genomic Classification of Cutaneous Melanoma
|Cell|2015|3.3k
Distinct Sets of Genetic Alterations in Melanoma
|New England Journal of Medicine|2005|2.7k
Somatic Activation of KIT in Distinct Subtypes of Melanoma
|Journal of Clinical Oncology|2006|1.6k